158 related articles for article (PubMed ID: 30226613)
1. UCA1 overexpression is associated with less aggressive subtypes of bladder cancer.
Lebrun L; Milowich D; Le Mercier M; Allard J; Van Eycke YR; Roumeguere T; Decaestecker C; Salmon I; Rorive S
Oncol Rep; 2018 Nov; 40(5):2497-2506. PubMed ID: 30226613
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis.
Xue M; Li X; Wu W; Zhang S; Wu S; Li Z; Chen W
Oncol Rep; 2014 May; 31(5):1993-2000. PubMed ID: 24648007
[TBL] [Abstract][Full Text] [Related]
3. Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
Avgeris M; Tsilimantou A; Levis PK; Rampias T; Papadimitriou MA; Panoutsopoulou K; Stravodimos K; Scorilas A
Carcinogenesis; 2019 Aug; 40(8):965-974. PubMed ID: 30815670
[TBL] [Abstract][Full Text] [Related]
4. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion.
Xue M; Li X; Li Z; Chen W
Tumour Biol; 2014 Jul; 35(7):6901-12. PubMed ID: 24737584
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer.
Zhen S; Hua L; Liu YH; Sun XM; Jiang MM; Chen W; Zhao L; Li X
Oncotarget; 2017 Feb; 8(6):9634-9646. PubMed ID: 28038452
[TBL] [Abstract][Full Text] [Related]
6. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
Shang C; Guo Y; Zhang J; Huang B
Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA urothelial carcinoma associated 1 induces cell replication by inhibiting BRG1 in 5637 cells.
Wang X; Gong Y; Jin B; Wu C; Yang J; Wang L; Zhang Z; Mao Z
Oncol Rep; 2014 Sep; 32(3):1281-90. PubMed ID: 24993775
[TBL] [Abstract][Full Text] [Related]
8. Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder.
Srivastava AK; Singh PK; Rath SK; Dalela D; Goel MM; Bhatt ML
Tumour Biol; 2014 Nov; 35(11):11435-42. PubMed ID: 25123267
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
Xue M; Pang H; Li X; Li H; Pan J; Chen W
Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer.
Chen P; Wan D; Zheng D; Zheng Q; Wu F; Zhi Q
Biomed Pharmacother; 2016 Oct; 83():1220-1226. PubMed ID: 27562722
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
Pan J; Li X; Wu W; Xue M; Hou H; Zhai W; Chen W
Cancer Lett; 2016 Nov; 382(1):64-76. PubMed ID: 27591936
[TBL] [Abstract][Full Text] [Related]
12. Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells.
Wu W; Zhang S; Li X; Xue M; Cao S; Chen W
PLoS One; 2013; 8(9):e73920. PubMed ID: 24069250
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients.
Li M; Cai Y; Zhao H; Xu Z; Sun Q; Luo M; Gu L; Meng M; Han X; Sun H
Tumour Biol; 2015 Jun; 36(6):4785-92. PubMed ID: 25647262
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients.
Liu X; Yao D; Liu C; Cao Y; Yang Q; Sun Z; Liu D
Tumour Biol; 2016 Jun; 37(6):8367-74. PubMed ID: 26733163
[TBL] [Abstract][Full Text] [Related]
15. Function of Long Noncoding RNA UCA1 on Gastric Cancer Cells and its Clinicopathological Significance in Plasma.
Tang X; Yu L; Bao J; Jiang P; Yan F
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710437
[TBL] [Abstract][Full Text] [Related]
16. C/EBPβ promotes the viability of human bladder cancer cell by contributing to the transcription of bladder cancer specific lncRNA UCA1.
Jin B; Gong Y; Li H; Jiao L; Xin D; Gong Y; He Z; Zhou L; Jin Y; Wang X; Zhang Z
Biochem Biophys Res Commun; 2018 Nov; 506(3):674-679. PubMed ID: 30376994
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA Urothelial Carcinoma Associated 1 (UCA1): Insight into Its Role in Human Diseases.
Li F; Hu CP
Crit Rev Eukaryot Gene Expr; 2015; 25(3):191-7. PubMed ID: 26558942
[TBL] [Abstract][Full Text] [Related]
18. The common region of lncRNAs UCA1 and UCA1α contributes to the bladder cancer tumorigenesis.
Wang Y; Li X; Chen W; Wu W
Eur J Cancer Prev; 2021 Sep; 30(5):389-392. PubMed ID: 33795587
[TBL] [Abstract][Full Text] [Related]
19. Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer.
Wang T; Yuan J; Feng N; Li Y; Lin Z; Jiang Z; Gui Y
Tumour Biol; 2014 Oct; 35(10):10075-84. PubMed ID: 25015192
[TBL] [Abstract][Full Text] [Related]
20. [Effects of lncRNA-UCA1 targeting miR-204-5p on the proliferation, migration, apoptosis and immune escape of endometrial carcinoma cells].
Jing S; Feng Y; He XL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):56-63. PubMed ID: 36709121
[No Abstract] [Full Text] [Related]
[Next] [New Search]
